Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2022-06-24 Sale |
2022-06-28 4:01 pm |
Jasper Therapeutics Inc. | JSPR | Lis William Director |
49,486 | $2.0498 | $101,434 | 40,486 (Direct) |
View |
| 2021-04-21 Sale |
2021-04-23 5:15 pm |
Amplitude Healthcare Acquisition Corp | AMHC | GLAZER CAPITAL LLC GLAZER PAUL J 10% Owner |
152,883 | $9.92 | $1,516,599 | 895,059 (Indirect) |
View |
| 2021-04-19 Sale |
2021-04-21 08:09 am |
Amplitude Healthcare Acquisition Corp | AMHC | GLAZER CAPITAL LLC GLAZER PAUL J 10% Owner |
2,060 | $9.97 | $20,538 | 1,047,942 (Indirect) |
View |
| 2021-02-18 Sale |
2021-02-22 6:13 pm |
Amplitude Healthcare Acquisition Corp | AMHC | GLAZER CAPITAL LLC GLAZER PAUL J 10% Owner |
12,810 | $10.46 | $134,005 | 1,050,002 (Indirect) |
View |
| 2021-02-05 Sale |
2021-02-09 5:45 pm |
Amplitude Healthcare Acquisition Corp | AMHC | GLAZER CAPITAL LLC GLAZER PAUL J 10% Owner |
212 | $10.4 | $2,205 | 1,062,812 (Indirect) |
View |
| 2021-01-14 Sale |
2021-01-19 7:04 pm |
Amplitude Healthcare Acquisition Corp | AMHC | GLAZER CAPITAL LLC GLAZER PAUL J 10% Owner |
101 | $10.4 | $1,050 | 1,063,024 (Indirect) |
View |
| 2021-01-08 Sale |
2021-01-12 7:31 pm |
Amplitude Healthcare Acquisition Corp | AMHC | GLAZER CAPITAL LLC GLAZER PAUL J 10% Owner |
10,000 | $10.25 | $102,500 | 1,063,125 (Indirect) |
View |
| 2020-12-29 Sale |
2020-12-31 6:00 pm |
Amplitude Healthcare Acquisition Corp | AMHC | GLAZER CAPITAL LLC GLAZER PAUL J 10% Owner |
93 | $10.25 | $953 | 1,073,125 (Indirect) |
View |
| 2020-12-22 Sale |
2020-12-28 6:50 pm |
Amplitude Healthcare Acquisition Corp | AMHC | GLAZER CAPITAL LLC GLAZER PAUL J 10% Owner |
20,000 | $10.18 | $203,500 | 1,073,218 (Indirect) |
View |
| 2020-12-11 Sale |
2020-12-15 6:26 pm |
Amplitude Healthcare Acquisition Corp | AMHC | GLAZER CAPITAL LLC GLAZER PAUL J 10% Owner |
20,000 | $10.1 | $202,000 | 1,093,218 (Indirect) |
View |
| 2020-09-04 Sale |
2020-12-09 7:02 pm |
Amplitude Healthcare Acquisition Corp | AMHC | GLAZER CAPITAL LLC GLAZER PAUL J 10% Owner |
12 | $10.67 | $128 | 1,113,218 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2022-10-12 Option Award |
2022-10-13 7:56 pm |
N/A N/A |
Jasper Therapeutics Inc. | JSPR | French Anna Louise Director |
30,750 | $0 | 30,750 (Direct) |
View |
Ownership |
2022-08-11 4:57 pm |
N/A N/A |
Jasper Therapeutics Inc. | JSPR | Carlyle Group Inc. Carlyle Holdings I GP Inc. Carlyle Holdings I GP Sub L.L.C. Carlyle Holdings I L.P. CG Subsidiary Holdings L.L.C. TC Group LLC Carlyle Investment Management LLC Carlyle Genesis UK LLC 10% Owner |
0 | $0 | 5,706,603 (Indirect) |
View |
| 2022-04-07 Option Award |
2022-04-08 4:01 pm |
N/A 2032-04-07 |
Jasper Therapeutics Inc. | JSPR | Mahal Jeetinder Singh See Remarks |
48,441 | $0 | 48,441 (Direct) |
View |
| 2022-03-21 Option Award |
2022-03-23 6:06 pm |
N/A 2032-03-21 |
Jasper Therapeutics Inc. | JSPR | MARTELL RON President, CEO and Director |
1,704,328 | $0 | 1,704,328 (Direct) |
View |
| 2022-03-21 Option Award |
2022-03-23 6:05 pm |
N/A 2032-03-21 |
Jasper Therapeutics Inc. | JSPR | Klein Lawrence Otto Director |
78,045 | $0 | 78,045 (Direct) |
View |
| 2022-03-21 Option Award |
2022-03-23 6:04 pm |
N/A 2032-03-21 |
Jasper Therapeutics Inc. | JSPR | EMSTER KURT VON Director 10% Owner |
78,045 | $0 | 78,045 (Direct) |
View |
| 2022-03-21 Option Award |
2022-03-23 6:04 pm |
N/A 2032-03-21 |
Jasper Therapeutics Inc. | JSPR | Heller Kevin N. See Remarks |
7,500 | $0 | 7,500 (Direct) |
View |
| 2022-03-21 Option Award |
2022-03-23 6:03 pm |
N/A 2032-03-21 |
Jasper Therapeutics Inc. | JSPR | Shizuru Judith Anne Director |
78,045 | $0 | 78,045 (Direct) |
View |
| 2022-03-21 Option Award |
2022-03-23 6:02 pm |
N/A 2032-03-21 |
Jasper Therapeutics Inc. | JSPR | Mahal Jeetinder Singh COO,CFO and CS |
94,772 | $0 | 94,772 (Direct) |
View |
| 2022-03-21 Option Award |
2022-03-23 6:01 pm |
N/A 2032-03-21 |
Jasper Therapeutics Inc. | JSPR | Nolet Chris Director |
78,045 | $0 | 78,045 (Direct) |
View |
| 2022-03-21 Option Award |
2022-03-23 6:01 pm |
N/A 2032-03-21 |
Jasper Therapeutics Inc. | JSPR | Lis William See Remarks |
197,472 | $0 | 287,444 (Direct) |
View |
| 2022-03-21 Option Award |
2022-03-23 6:00 pm |
N/A 2032-03-21 |
Jasper Therapeutics Inc. | JSPR | French Anna Louise Director |
78,045 | $0 | 78,045 (Direct) |
View |
| 2022-03-21 Option Award |
2022-03-23 5:30 pm |
N/A 2032-03-21 |
Jasper Therapeutics Inc. | JSPR | Abingworth LLP 10% Owner |
78,045 | $0 | 78,045 (Indirect) |
View |
Ownership |
2021-10-04 09:10 am |
N/A N/A |
Jasper Therapeutics Inc. | JSPR | ROCHE HOLDING LTD ROCHE FINANCE LTD 10% Owner |
0 | $0 | 4,624,606 (Direct) |
View |
Ownership |
2021-10-01 4:30 pm |
N/A N/A |
Jasper Therapeutics Inc. | JSPR | Abingworth LLP 10% Owner |
0 | $0 | 5,628,558 (Indirect) |
View |
Ownership |
2021-10-01 4:12 pm |
N/A N/A |
Jasper Therapeutics Inc. | JSPR | EMSTER KURT VON Director 10% Owner |
0 | $0 | 5,628,558 (Indirect) |
View |
Ownership |
2021-10-01 4:10 pm |
N/A 2030-09-01 |
Jasper Therapeutics Inc. | JSPR | Heller Kevin N. EVP, Research and Development |
0 | $0 | 657,769 (Direct) |
View |
Ownership |
2021-10-01 4:10 pm |
N/A N/A |
Jasper Therapeutics Inc. | JSPR | Shizuru Judith Anne Director |
0 | $0 | 1,275,682 (Direct) |
View |
Ownership |
2021-10-01 4:09 pm |
N/A N/A |
Jasper Therapeutics Inc. | JSPR | Mahal Jeetinder Singh See remarks |
0 | $0 | 292,340 (Direct) |
View |
Ownership |
2021-10-01 4:08 pm |
N/A 2030-05-31 |
Jasper Therapeutics Inc. | JSPR | Lis William Chief Executive Officer |
0 | $0 | 959,945 (Direct) |
View |
Ownership |
2021-10-01 4:08 pm |
N/A N/A |
Jasper Therapeutics Inc. | JSPR | Qiming U.S. Healthcare Fund II L.P. Qiming U.S. Healthcare GP II LLC MCDADE MARK 10% Owner |
0 | $0 | 5,852,982 (Direct) |
View |
| 2021-09-24 Exercise |
2021-09-28 4:33 pm |
N/A N/A |
Amplitude Healthcare Acquisition Corp | JSPR | Clifford Kenneth F FORMER OFFICER |
2,300,000 | $0 | 2,300,000 (Indirect) |
View |
| 2021-09-24 Exercise |
2021-09-28 4:32 pm |
N/A N/A |
Amplitude Healthcare Acquisition Corp | JSPR | HOFFEN HOWARD I FORMER DIRECTOR Director |
2,300,000 | $0 | 2,300,000 (Indirect) |
View |
| 2021-09-24 Exercise |
2021-09-28 4:32 pm |
N/A N/A |
Amplitude Healthcare Acquisition Corp | JSPR | VENKATARAMAN BALAJI FORMER DIRECTOR AND OFFICER Director |
2,300,000 | $0 | 2,300,000 (Indirect) |
View |
| 2021-09-24 Exercise |
2021-09-28 4:29 pm |
N/A N/A |
Amplitude Healthcare Acquisition Corp | JSPR | Amplitude Healthcare Holdings LLC 10% Owner |
2,300,000 | $0 | 2,300,000 (Direct) |
View |